ROYAL BANK OF CANADA

Bank

Position in VSTM — Verastem, Inc.

CIK 1000275 TORONTO, A6

Position in VSTM

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$586,863

-$154,610 QoQ

Shares Held

110,729

+15.3% QoQ

Ownership

0.126%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 98.49813508656268.ToString("F0")% Shared 0.ToString("F0")% None 1.5018649134373108.ToString("F0")%

Healthcare · as of Mar 31, 2026

ROYAL BANK OF CANADA holds $1,974,352,961 across 412 Biotechnology names. VSTM ranks #65 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,111,871	$496,494,870
2	IONS	Ionis Pharmaceuticals Inc	3,801,815	$285,478,282
3	REGN	Regeneron Pharmaceuticals, Inc.	351,171	$271,328,756
4	ALNY	Alnylam Pharmaceuticals, Inc.	791,515	$261,888,563
5	INCY	Incyte Corp	1,054,123	$99,214,053
6	INSM	INSMED Inc	523,101	$85,537,473
7	MRNA	Moderna, Inc.	999,340	$50,766,470
8	HALO	Halozyme Therapeutics, Inc.	658,290	$42,545,279

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$586,863	110,729	+15.3%	Shares	Defined	2026-05-15
2025-12-31	$741,473	96,046	-76.7%	Shares	Defined	2026-02-17
2025-09-30	$3,642,735	412,541	+4.9%	Shares	Defined	2025-11-14
2025-06-30	$1,632,567	393,390	+311.3%	Shares	Defined	2025-11-21
2025-03-31	$576,798	95,655	-64.7%	Shares	Defined	2025-11-21
2024-12-31	$1,400,133	270,819	+354.0%	Shares	Defined	2025-02-14
2024-09-30	$178,373	59,657	+4.4%	Shares	Defined	2024-11-14
2024-06-30	$170,348	57,164	+7.1%	Shares	Defined	2024-11-06
2024-03-31	$629,919	53,383	-2.3%	Shares	Defined	2024-11-05
2023-12-31	$444,940	54,661	+28.5%	Shares	Defined	2024-02-14
2023-09-30	$345,881	42,544	-57.2%	Shares	Defined	2023-11-14
2023-06-30	$739,193	99,354	—	Shares	Defined	2023-08-14
No filing history on record for this holder in this stock.